abstract |
The present invention is directed to a composition containing a low dose brimonidine and a second glaucoma drug, either an antihistamine or a nonsteroidal anti-inflammatory drug. The present invention is further directed to methods of treating glaucoma or allergies or reducing inflammation by administering the compositions of the present invention. |